ChromaDex (NASDAQ: CDXC) reported Q2 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $22.7 million versus the consensus estimate of $23.33 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.